These data also extend our knowledge of the complex aspects of Stra6-mediated signaling and vitamin A metabolism in the context of ischemic heart disease and emphasize the need for further studies before using vitamin A metabolites to treat cardiovascular disease. This evidence concerns the gene STRA6 and coronary artery disorder.